tirzepatide class action lawsuit Trulicity [2026] Mounjaro Lawsuit | July 2026

Aroda VR, Aberle J, Bardtrum L, Christiansen E, Knop FK, Gabery S, Pedersen SD, Buse JB

(1993) Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns

Initial onset during dose increases, gradual improvement with continued treatment, and minimal long-term impact on quality of life for most participants

Estimated at 46 hours based on pharmacokinetic modeling

(2022) Tirzepatide - a dual GIP/GLP-1 receptor agonist - a new antidiabetic drug with potential metabolic activity in the treatment of type 2 diabetes